Osimertinib early dose reduction as a risk to brain metastasis control in EGFR‐mutant non‐small cell lung cancer

por Tozuka, Takehiro, Noro, Rintaro, Miyanaga, Akihiko, Nakamichi, Shinji, Takeuchi, Susumu, Matsumoto, Masaru, Kubota, Kaoru, Kasahara, Kazuo, Seike, Masahiro
Publicado 2023

Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer

por Omori, Miwako, Noro, Rintaro, Seike, Masahiro, Matsuda, Kuniko, Hirao, Mariko, Fukuizumi, Aya, Takano, Natsuki, Miyanaga, Akihiko, Gemma, Akihiko
Publicado 2022

Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLC

por Terashima, Yuto, Matsumoto, Masaru, Iida, Hiroki, Takashima, Sae, Fukuizumi, Aya, Takeuchi, Susumu, Miyanaga, Akihiko, Terasaki, Yasuhiro, Kasahara, Kazuo, Seike, Masahiro
Publicado 2023

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer

por Matsumoto, Masaru, Seike, Masahiro, Noro, Rintaro, Soeno, Chie, Sugano, Teppei, Takeuchi, Susumu, Miyanaga, Akihiko, Kitamura, Kazuhiro, Kubota, Kaoru, Gemma, Akihiko
Publicado 2015

miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells

por NISHIJIMA, NOBUHIKO, SEIKE, MASAHIRO, SOENO, CHIE, CHIBA, MIKA, MIYANAGA, AKIHIKO, NORO, RINTARO, SUGANO, TEPPEI, MATSUMOTO, MASARU, KUBOTA, KAORU, GEMMA, AKIHIKO
Publicado 2016

Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial–mesenchymal transition is critical in conquering ALK-positive lung cancer

por Nakamichi, Shinji, Seike, Masahiro, Miyanaga, Akihiko, Chiba, Mika, Zou, Fenfei, Takahashi, Akiko, Ishikawa, Arimi, Kunugi, Shinobu, Noro, Rintaro, Kubota, Kaoru, Gemma, Akihiko
Publicado 2018

The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non‐small cell lung cancer

por Shimizu, Masamitsu, Miyanaga, Akihiko, Seike, Masahiro, Matsuda, Kuniko, Matsumoto, Masaru, Noro, Rintaro, Fujita, Kazue, Mano, Yoko, Furuya, Nobuhiko, Kubota, Kaoru, Gemma, Akihiko
Publicado 2022

Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case report

por Fukuizumi, Aya, Miyanaga, Akihiko, Seike, Masahiro, Kato, Yasuhiro, Nakamichi, Shinji, Chubachi, Kumi, Matsumoto, Masaru, Noro, Rintaro, Minegishi, Yuji, Kunugi, Shinobu, Kubota, Kaoru, Gemma, Akihiko
Publicado 2015

Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report

por Kato, Yuki, Kato, Yasuhiro, Minegishi, Yuji, Suzuki, Takahiro, Nakamichi, Shinji, Matsumoto, Masaru, Miyanaga, Akihiko, Noro, Rintaro, Kubota, Kaoru, Terasaki, Yasuhiro, Seike, Masahiro, Gemma, Akihiko
Publicado 2021

Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report

por Misawa, Kazuhito, Nakamichi, Shinji, Iida, Hiroki, Nagano, Atsuhiro, Mikami, Erika, Tozuka, Takehiro, Matsumoto, Masaru, Miyanaga, Akihiko, Noro, Rintaro, Kubota, Kaoru, Yamaguchi, Hiroki, Seike, Masahiro
Publicado 2023

Bevacizumab plus chemotherapy in nonsquamous non‐small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study Nort...

por Noro, Rintaro, Kobayashi, Kunihiko, Usuki, Jiro, Yomota, Makiko, Nishitsuji, Masaru, Shimokawa, Tsuneo, Ando, Masahiro, Hino, Mitsunori, Hagiwara, Koichi, Miyanaga, Akihiko, Seike, Masahiro, Kubota, Kaoru, Gemma, Akihiko
Publicado 2020

Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case...

por Iso, Hirokazu, Miyanaga, Akihiko, Kadoma, Naohiro, Shinbu, Kaoruko, Tozuka, Takehiro, Murata, Akari, Nishima, Shunichi, Sato, Yozo, Nakamichi, Shinji, Matsumoto, Masaru, Noro, Rintaro, Terasaki, Yasuhiro, Kubota, Kaoru, Seike, Masahiro
Publicado 2023

Successful Treatment with Afatinib after Osimertinib-induced Interstitial Lung Disease in a Patient with EGFR-mutant Non-small-cell Lung Cancer

por Nishima, Shunichi, Miyanaga, Akihiko, Saito, Sho, Yuasa, Mizuki, Takahashi, Satoshi, Kashiwada, Takeru, Sugano, Teppei, Noro, Rintaro, Minegishi, Yuji, Terasaki, Yasuhiro, Saito, Yoshinobu, Kubota, Kaoru, Seike, Masahiro, Gemma, Akihiko
Publicado 2020

Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pemb...

por Hayashi, Anna, Nakamichi, Shinji, Nakayama, Yukako, Nagano, Atsuhiro, Mikami, Erika, Takano, Natsuki, Tozuka, Takehiro, Matsumoto, Masaru, Miyanaga, Akihiko, Noro, Rintaro, Terasaki, Yasuhiro, Kubota, Kaoru, Seike, Masahiro, Gemma, Akihiko
Publicado 2022

Oral rehydration solution (OS-1) as a substitute of intravenous hydration after cisplatin administration in patients with lung cancer: a prospective multicenter trial

por Horinouchi, Hidehito, Kubota, Kaoru, Miyanaga, Akihiko, Nakamichi, Shinji, Seike, Masahiro, Gemma, Akihiko, Yamane, Yuki, Kurimoto, Futoshi, Sakai, Hiroshi, Kanda, Shintaro, Fujiwara, Yutaka, Nokihara, Hiroshi, Yamamoto, Noboru, Tamura, Tomohide, Ohe, Yuichiro
Publicado 2018

Immune checkpoint inhibitor‐associated interstitial lung diseases correlate with better prognosis in patients with advanced non‐small‐cell lung cancer

por Sugano, Teppei, Seike, Masahiro, Saito, Yoshinobu, Kashiwada, Takeru, Terasaki, Yasuhiro, Takano, Natsuki, Hisakane, Kakeru, Takahashi, Satoshi, Tanaka, Toru, Takeuchi, Susumu, Miyanaga, Akihiko, Minegishi, Yuji, Noro, Rintaro, Kubota, Kaoru, Gemma, Akihiko
Publicado 2020

CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis

por Fukuizumi, Aya, Noro, Rintaro, Seike, Masahiro, Miyanaga, Akihiko, Minegishi, Yuji, Omori, Miwako, Hirao, Mamiko, Matsuda, Kuniko, Kunugi, Shinobu, Nishiwaki, Kazutaka, Morimoto, Masahiro, Motohashi, Haruka, Ohwada, Hayato, Usuda, Jitsuo, Gemma, Akihiko
Publicado 2021

Carboplatin plus nanoparticle albumin-bound paclitaxel for the treatment of thymic carcinoma

por Takahashi, Akiko, Noro, Rintaro, Takano, Natsuki, Hisakane, Kakeru, Takahashi, Satoshi, Fukuizumi, Aya, Omori, Miwako, Sugano, Teppei, Takeuchi, Susumu, Nakamichi, Shinji, Miyanaga, Akihiko, Minegishi, Yuji, Kubota, Kaoru, Seike, Masahiro, Gemma, Akihiko
Publicado 2022

EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells

por Miyanaga, Akihiko, Matsumoto, Masaru, Beck, Jessica A., Horikawa, Izumi, Oike, Takahiro, Okayama, Hirokazu, Tanaka, Hiromi, Burkett, Sandra S., Robles, Ana I., Khan, Mohammed, Lissa, Delphine, Seike, Masahiro, Gemma, Akihiko, Mano, Hiroyuki, Harris, Curtis C.
Publicado 2021

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation

por Miyanaga, Akihiko, Shimizu, Kumi, Noro, Rintaro, Seike, Masahiro, Kitamura, Kazuhiro, Kosaihira, Seiji, Minegishi, Yuji, Shukuya, Takehito, Yoshimura, Akinobu, Kawamoto, Masashi, Tsuchiya, Shinichi, Hagiwara, Koichi, Soda, Manabu, Takeuchi, Kengo, Yamamoto, Nobuyuki, Mano, Hiroyuki, Ishikawa, Yuichi, Gemma, Akihiko
Publicado 2013